ATP-phosphopeptide conjugates as inhibitors of Src tyrosine kinases

Nguyen Hai Nam, Sungsoo Lee, Guofeng Ye, Gongqin Sun, Keykavous Parang

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


ATP-phosphopeptide conjugates were synthesized and evaluated in vitro against c-Src and Lck. A number of Src SH2 domain inhibitors enhance the kinase catalytic activity by switching the closed inactive to the open active conformation. ATP-phosphopeptide conjugates were designed and synthesized as Src tyrosine kinase inhibitors based on a tetrapeptide sequence pTyr-Glu-Glu-Ile (pYEEI) and ATP to block the SH2 domain signaling and substrate phosphorylation by ATP, respectively. In general, ATP-phosphopeptide conjugates with optimal linkers such as compounds 5 and 7 (K i = 1.7-2.6 μM) showed higher binding affinities to the ATP-binding site relative to the other ATP-phosphopeptide conjugates having short or long linkers, 1-4 and 6, (K i = 10.1-16.1 μand ATP (K m = 74 μM). These ATP-phosphopeptide conjugates may serve as novel templates for designing protein tyrosine kinase inhibitors to block SH2 mediated protein-protein interactions and to counter the activation of enzyme that resulted from the SH2 inhibition.

Original languageEnglish (US)
Pages (from-to)5753-5766
Number of pages14
JournalBioorganic and Medicinal Chemistry
Issue number22
StatePublished - Nov 15 2004
Externally publishedYes


  • Inhibitors
  • pYEEI
  • Src SH2 domain
  • Src tyrosine kinases

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science


Dive into the research topics of 'ATP-phosphopeptide conjugates as inhibitors of Src tyrosine kinases'. Together they form a unique fingerprint.

Cite this